Comparison of chromosomal aberrations in primary colorectal carcinomas to their pulmonary metastases

Pulmonary metastases (PM) are frequent in colorectal carcinoma (CRC). However, little is known about the chromosomal imbalances in CRC that accompany metastatic pulmonary disease. We investigated tumor specimens of CRC ( n = 30) and their corresponding PM by comparative genomic hybridization (CGH)....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer genetics 2011-03, Vol.204 (3), p.122-128
Hauptverfasser: Danner, Bernhard C, Gerdes, Jan S, Jung, Klaus, Sander, Björn, Enders, Christina, Liersch, Torsten, Seipelt, Ralf, Gutenberg, Angelika, Gunawan, Bastian, Schöndube, Friedrich A, Füzesi, Laszlo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Pulmonary metastases (PM) are frequent in colorectal carcinoma (CRC). However, little is known about the chromosomal imbalances in CRC that accompany metastatic pulmonary disease. We investigated tumor specimens of CRC ( n = 30) and their corresponding PM by comparative genomic hybridization (CGH). There were no substantial differences in the degree of chromosomal instability between CRC and PM, neither in average number of copy alterations (ANCA; 6.6 ± 0.8 and 7.7 ± 0.9) nor in gains (2.6 ± 0.5 and 2.6 ± 0.4), losses (3.6 ± 0.5 and 4.8 ± 0.6), or amplifications (0.4 ± 0.1 and 0.3 ± 0.1). Basically, similar patterns of chromosomal imbalances could be identified in both CRC and corresponding PM, most frequently including chromosomal gains at 7, 8q, 13q, and 20q, as well as losses at 4, 8p, 18q, and 20p. CRC and corresponding PM differed in frequencies for losses at chromosome arm 5q (3 vs. 26%; P = 0.012). Losses at 4q and 11q in CRC were significantly associated with lower 5-year survival rates (80 vs. 24%, P = 0.026 and 74 vs. 17%, P = 0.007, respectively), and they may represent candidates for adverse prognostic markers in primary CRC.
ISSN:2210-7762
DOI:10.1016/j.cancergen.2010.12.003